Christer Peterson

Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease

Venge, Byström, Carlson, 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils.

A. Engström, P. Venge, C. Peterson, 1994, Scandinavian journal of clinical and laboratory investigation.

Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia.

P. Venge, L. Håkansson, C. Peterson, 1991, The Journal of allergy and clinical immunology.

Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season.

P. Venge, L. Håkansson, G. Stålenheim, 1992, The Journal of allergy and clinical immunology.

The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.

P. Venge, C. Peterson, M. Carlson, 1993, Allergy.

Eosinophil granule proteins in serum after allergen challenge of asthmatic patients and the effects of anti-asthmatic medication.

R. Dahl, P. Venge, C. Peterson, 1988, International archives of allergy and applied immunology.

Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma.

J. Bousquet, P. Chanez, P. Venge, 1991, The Journal of allergy and clinical immunology.

Faecal biomarkers for diagnosis and prediction of disease course in treatment-naïve patients with IBD.

J. Halfvarson, M. Lampinen, D. Bergemalm, 2024, Alimentary pharmacology & therapeutics.